首页> 外文期刊>Frontiers in Immunology >A Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population
【24h】

A Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population

机译:26种候选基因和促炎性细胞因子变异体的数据集,用于特发性肺纤维化的关联研究:正常捷克人群中的频率分布

获取原文
           

摘要

Introduction Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia with poor diagnosis and a median survival of 2–3?years from initial diagnosis ( 1 , 2 ). The cellular inflammation drives the fibrotic response in lung and plays a major role in IPF pathogenesis ( 3 ). Inflammatory cells (majorly, type 2 alveolar epithelial cells) release TGF-β, the key mediator of pulmonary fibrosis, that regulates several profibrotic cytokines/chemokines, their receptors, receptor subunits, and growth factors inducing process of epithelial–mesenchymal transition (EMT) ( 3 , 4 ). Among the pro-inflammatory and profibrotic cytokines involved in IPF pathogenesis, interleukin (IL)-1 ( 4 ), IL-1β ( 5 ), IL-4, IL-5 ( 6 ), IL-6Rα ( 4 ), angiogenic IL-8/CXCL-8 ( 7 ), IL-13, its receptor IL-13 Rα2 ( 8 ), and IL-33 ( 9 ) have been implicated in accelerated inflammation and irreversible damage to lung architecture with loss of alveolar-capillary barrier basal membrane leading to persistent fibrosis. Genes encoding these factors exhibit nucleotide variation that could affect the severity of immune/inflammatory reactions and extent of any subsequent dysregulated fibroproliferative activity in disease development. Furthermore, variants in mucin-encoding genes ( 10 – 13 ) and in genes for pathogen-associated molecular patterns (PAMPs) receptors of innate immunity known as toll-like receptors (TLRs) ( 14 , 15 ) have been also implicated in IPF immunopathogenesis and related to rapid progression of the disease. Investigations of these “candidate” gene variant(s) e.g., in case-control association studies may, therefore, provide novel insight into underlying mechanism of IPF susceptibility/disease outcome and, further, may aid to develop novel diagnostic approaches and eventually therapeutic interventions based on genetic information ( 16 ).A candidate gene study typically involves genotyping 5–50 single nucleotide polymorphisms (SNPs) within gene(s) for its coding and non-coding/regulatory regions ( 17 ). Irrespective of the number of tested gene variants; for a standard conductance, data collection, and transparent reporting of a genetic association study, the recommendations of STrengthening the REporting of Genetic Association studies (STREGA) and STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) should be considered ( 16 ). In case-control studies, knowledge of frequency distribution of candidate gene loci/variants among normal (healthy control) population(s) is necessary and could be useful also for genetically related population(s) to determine the gene variants associated with disease and/or its clinical course.The role of inflammatory and profibrotic mechanisms involving gene variation has been investigated in IPF and spectrum of susceptible polymorphic gene variants, including those in genes of immune reactions and signaling processes, have been recently reported from both genome-wide association studies (GWAS) and population-based case-control studies ( 14 , 18 , 19 ) performed mostly in US Caucasians, and also in some other ethnicities. The nominated gene variants, summarized in Table 1 , are of different functions and implicate some yet-unanticipated pathways in IPF pathogenesis, including endoplasmic reticulum stress and unfolded protein response, cellular senescence, DNA-damage response, and already known Wnt–β-catenin signaling ( 20 ). The distribution of SNPs may greatly differ with populations (ethnicities), for example, a high frequency of MUC5B rs35705950*T allele in IPF cases is observed among European-Americans (14–34%) ( 21 , 22 ), while its low frequency is characteristic for Asians, such as Chinese (3.3%) ( 23 ), Japanese (3.4%) ( 24 ), and Korean (1.0%) cohorts ( 11 ). Similarly, MUC2 rs7934606*A allele exhibit frequency of 41% in Europeans and 1% in Asians (1000 Genomes Project Phase 3 allele frequencies). Furthermore, in context of participation of more than one gene in IPF pathogenesis, it will be important to analyze multiple susceptible gene variants. The approach of analyzing common and rare genetic factors in IPF susceptibility may provide novel insights into IPF and it could also be helpful in identifying population-specific rare variants, predominant panel of candidate gene variants for IPF risk and in understanding the basis of variable disease severity or progression among different populations. Table 1 List of candidate SNPs investigated in the study . S.No. Location Gene SNP ID Position Region Functional category Reference 1 2q14.1 IL-1 α rs1800587 112,785,383 5′-flanking region Pro-inflammatory cytokine ( 25 ) 2 2q14.1 IL-1 β rs16944 112,837,290 Promoter Pro-inflammatory cytokine ( 25 ) 3 2q14.1 IL-1 β rs1143634 112,832,813 Exon (d_(S)) Pro-inflammatory cytokine ( 25 ) 4 2p21 PRKCE rs628877 45,698,441 Intron Cellular signaling pathways – 5 3q26 LRRC34 rs6793295 169,800,667 Exon (d_(N)) Protein-protein interaction ( 2
机译:引言特发性肺纤维化(IPF)是慢性进行性纤维化间质性肺炎的一种特殊形式,诊断不佳,从最初诊断起中位生存期为2-3年(1,2)。细胞炎症驱动肺中的纤维化反应,并在IPF发病机理中起主要作用(3)。炎性细胞(主要是2型肺泡上皮细胞)释放TGF-β,这是肺纤维化的关键介质,它调节几种促纤维化细胞因子/趋化因子,其受体,受体亚基和上皮-间质转化(EMT)的诱导过程。 (3,4)。在IPF发病机制中涉及的促炎和纤维化细胞因子中,白介素(IL)-1(4),IL-1β(5),IL-4,IL-5(6),IL-6Rα(4),血管生成性IL -8 / CXCL-8(7),IL-13,其受体IL-13Rα2(8)和IL-33(9)与加速炎症反应和肺结构不可逆性损伤有关,肺泡-毛细血管屏障丧失基底膜导致持续性纤维化。编码这些因子的基因表现出核苷酸变异,可能影响免疫/炎症反应的严重程度以及疾病发展过程中随后任何失调的纤维增生活性的程度。此外,粘蛋白编码基因(10-13)和与生俱来的免疫相关的病原体相关分子模式(PAMPs)受体基因中的变体,也被称为toll样受体(TLR)(14、15),也与IPF免疫发病机制有关。与疾病的快速发展有关。因此,例如在病例对照研究中对这些“候选”基因变异的研究可能提供对IPF易感性/疾病结果的潜在机制的新颖见解,并且进一步有助于开发新颖的诊断方法和最终的治疗性干预措施。基于遗传信息(16)。候选基因研究通常涉及对基因中编码和非编码/调控区的5-50个单核苷酸多态性(SNP)进行基因分型(17)。不论测试的基因变体的数量如何;对于标准的电导率,数据收集和遗传协会研究的透明报告,应考虑加强遗传协会研究报告(STREGA)和加强流行病学观察研究报告(STROBE)的建议(16)。在病例对照研究中,了解正常(健康对照)人群中候选基因位点/变体的频率分布是必要的,并且对于遗传相关人群确定与疾病和/或疾病相关的基因变体也可能有用涉及基因变异的炎症和纤维化机制的作用已在IPF中进行了研究,最近两项全基因组关联研究均报道了易感多态基因变异的频谱,包括免疫反应和信号传导过程的基因变异。 (GWAS)和基于人群的病例对照研究(14,18,19)主要在美国白种人中以及其他种族中进行。表1总结了提名的基因变异,它们具有不同的功能,并暗示IPF发病机理中一些尚未预料到的途径,包括内质网应激和未折叠的蛋白应答,细胞衰老,DNA损伤应答以及已知的Wnt-β-catenin信令(20)。 SNP的分布可能随人群(族裔)而有很大差异,例如,在IPF病例中,在欧洲裔美国人(14–34%)中观察到MUC5B rs35705950 * T等位基因的频率很高(21,22),而其频率较低对于中国人(3.3%)(23),日本人(3.4%)(24)和韩国人(1.0%)队列(11)等亚洲人来说是很典型的特征。同样,MUC2 rs7934606 * A等位基因在欧洲人中的频率为41%,在亚洲人中为1%(1000个基因组计划第3阶段等位基因频率)。此外,在不止一个基因参与IPF发病机理的背景下,分析多种易感基因变异将很重要。分析IPF易感性的常见和稀有遗传因素的方法可能为IPF提供新颖的见解,也可能有助于识别特定人群的稀有变种,IPF风险的主要候选基因变种以及了解疾病严重程度的基础或不同人群之间的进展。表1:研究中调查的候选SNP列表。序号位置基因SNP ID位置区域功能类别参考1 2q14.1 IL-1αrs1800587 112,785,383 5'侧翼区促炎细胞因子(25)2 2q14.1 IL-1βrs16944 112,837,290启动子促炎细胞因子(25)3 2q14.1 IL-1βrs1143634 112,832,813外显子(d_(S))促炎细胞因子(25)4 2p21 PRKCE rs628877 45,698,441内含子细胞信号传导途径– 5 3q26 LRRC34 rs6793295 169,800,667外显子(d_(N))蛋白质-蛋白质相互作用( 2

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号